Navigation Links
Breast Augmentation – FDA Approves New Silicone Gel Implant
Date:6/22/2013

Los Angeles, CA (PRWEB) June 22, 2013

According to a June 14, 2013 NBC News report, titled “FDA Approves Mentor's New Silicone Gel Breast Implant,” the FDA has approved the Mentor MemoryShape Breast Implant, making it the fifth silicone implant to receive such approval in the United States. Though the approval comes with strict stipulations for monitoring patients, the FDA found the implant to be safe for use in breast augmentation and reconstruction. They did, however, require that the manufacturer commit to extensive additional testing and continued monitoring of the original test group (go to goo.gl/DX4vp).

“The approval of the MemoryShape breast implant means women now have another choice for their breast augmentation or reconstruction,” says Dr. Simon Ourian, Medical Director of Epione Beverly Hills.

According to the report, the FDA determined that women have a "reasonable" expectation of safety and that the side effects from the MemoryShape implant were similar to those experienced with other implants. These problems included hardening of the skin around the implants causing them to be encapsulated, an uneven appearance, and cracking. These complications are not unusual for any of the FDA approved silicone devices.

Further according to the NBC report, the FDA has required that Mentor carefully monitor the women in the study for an additional 10 years. Also, the company must monitor another 350 women who will receive a type of MemoryShape device for five full years. The FDA has further stipulated that Mentor study 2,500 additional women who get MemoryShape implants for ten years to watch for long-term problems. As another safeguard, Mentor must perform five control studies involving 10,750 women to watch for an association with diseases that include brain and cervical cancer.

“The testing before approval was extensive and the continued testing and monitoring required of Mentor by the FDA is strict and quite large in scope,” says Dr. Ourian, “reflecting the FDA's concern for possible links between implants and rare diseases.”

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvéderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about silicone breast implants can be found on Epione’s website

Read the full story at http://www.prweb.com/releases/2013/6/prweb10859542.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Trends in Venezuela Raise Awareness of Breast-Feeding Benefits
2. Mercy Takes Leadership Role in Use of Medical Technology, Offering IORT for Breast Cancer Patients and New National Institute of Robotic Surgery at Mercy
3. Third Generation California Vintner Cheryl Indelicato Makes Strides in the Fight Against Breast Cancer
4. FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery
5. EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer
6. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
7. Fat cells in breast may connect social stress to triple-negative breast cancer
8. Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
9. Abnormalities in new molecular pathway may increase breast cancer risk
10. U.S. Supreme Court Invalidates Patents on Breast and Ovarian Cancer Genes
11. Protein protects against breast cancer recurrence in animal model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... , ... Galena, Alaska, has a population of less than 500 people. But, ... targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The Galena ... describes the journey to get power to his small town, off the electrical grid. ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, ... investing in InsightRX, an early stage company in San Francisco that has developed ... Greatpoint Ventures Innovation Fund acted as the lead investor in the ...
(Date:5/21/2017)... ... 2017 , ... GetLinked® software continues to enhance ... systems. , Dozens of clubs using ABC Financial Services are now connected using ... their club’s accounting system , The latest implementation is Riverside Health Club ...
(Date:5/21/2017)... ... May 21, 2017 , ... For the ... cross-disciplinary group of scholars, policymakers, and activists wanting to address equity issues in ... is the third book from a recent series of from this conference. ...
(Date:5/21/2017)... ... , ... Following the tragic and widely publicized death of Rory Staunton, 12, ... hospitals follow a protocol to quickly identify and treat the condition. , The ... would have saved Rory or anyone else’s life. , Now, five years after ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data ... its 2017 ranking of the Best-Equipped Hospitals in Latin ... from GHI,s hospitals database for Latin America , which ... GHI database covers 86% of the hospitals in ... for each institution in key areas such as beds, medical ...
(Date:5/10/2017)... GLEN BURNIE, Md. , May 10, 2017 /PRNewswire/ ... and retention solutions for the clinical research industry, is ... website, www.CSSiEnroll.com . The new website features both ... better overall user experience and enhances the company,s already ... in the industry. "After many months ...
(Date:5/9/2017)...  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... focused on the development of oral drug delivery ... Office has granted Oramed a patent titled, "Methods ... patent covers Oramed,s invention of an oral glucagon-like ... incretin hormone that stimulates the secretion of insulin ...
Breaking Medicine Technology: